Mesothelioma Clinical Trials

219 clinical trials for Mesothelioma across international registries, including 40 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome — RECRUITING
• Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma — RECRUITING · PHASE1
• Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1 — RECRUITING
• A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma — RECRUITING
• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors — RECRUITING · PHASE1
• Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) — RECRUITING · PHASE1
• A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma — RECRUITING · PHASE2
• A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers — RECRUITING · PHASE1
• Prospective Data Collection Initiative on Thoracic Malignancies — RECRUITING
• Lead-212 PSV359 Therapy for Patients With Solid Tumors — RECRUITING · PHASE1
• Integrated Cancer Repository for Cancer Research — RECRUITING
• A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression — RECRUITING · PHASE1
• Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing — RECRUITING
• A Study of Sacituzumab Govitecan in People With Mesothelioma — RECRUITING · PHASE2
• A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products — RECRUITING
• 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection — RECRUITING · PHASE2
• Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers — RECRUITING · NA
• A 2-part Phase 1/2 Open-label Trial on ODM-212 — RECRUITING · PHASE1
• Agnostic Therapy in Rare Solid Tumors — RECRUITING · PHASE2
• A Study of VET3-TGI in Patients With Solid Tumors — RECRUITING · PHASE1
• Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors — RECRUITING · PHASE1
• Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome — RECRUITING
• Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma — RECRUITING · NA
• Molecular Analysis of Thoracic Malignancies — RECRUITING
• VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma — RECRUITING · PHASE1
• Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion — RECRUITING · PHASE1
• MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI — RECRUITING · PHASE2
• Stereotactic Magnetic Resonance Guided Radiation Therapy — RECRUITING · NA
• Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU — RECRUITING · NA
• Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma — RECRUITING · PHASE1
• Immune Microenvironment and Gene Expression Profiling in Mesothelioma — RECRUITING
• An International Study on Pediatric Patients With Rare Tumors. — RECRUITING
• Olaparib in Patients With HRD Malignant Mesothelioma — RECRUITING · PHASE2
• A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors — RECRUITING · PHASE1
• New Preclinical and Clinical Approaches to Mesothelioma — RECRUITING
• GPC3/Mesothelin-CAR-γδT Cells Against Cancers — RECRUITING · PHASE1
• First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies — RECRUITING · PHASE1
• SURGERY FOR MESOTHELIOMA AFTER RADIATION THERAPY USING EXQUISITE SYSTEMIC THERAPY — RECRUITING
• Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies — RECRUITING
• A randomised Phase II trial to assess whether niraparib is beneficial in patients with mesothelioma that has progressed and been previously treated when compared to the standard of care treatment, termed active symptom control — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (L-001079038) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy — TERMINATED · PHASE3
• Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma — ACTIVE_NOT_RECRUITING · PHASE2
• Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma — COMPLETED · PHASE1
• Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma — TERMINATED · PHASE2
• FAPI PET Imaging - An Exploratory Study — NOT_YET_RECRUITING · PHASE1
• A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer — TERMINATED · PHASE1
• A Study of SGN-MesoC2 in Advanced Solid Tumors — TERMINATED · PHASE1
• A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors — TERMINATED · PHASE1

Refine this search